PHILADELPHIA – A study conducted by researchers at the University of Pennsylvania School of Medicine and colleagues, and published in Reproductive Toxicology, found that maternal exposure to C8, a chemical used in the manufacture of non-stick surfaces, was not associated with either lowered birth weight or increased risk of preterm birth in Little Hocking, Ohio area residents. These findings are based on an examination of the vital records of newborns in Washington County, Ohio who were exposed to significant amounts of C8 through residential drinking water. Although C8 was not associated with lowered birth weight or increased risk of preterm birth, the authors noted that additional research is still required to confirm these findings and to investigate other potentially adverse health effects of C8 on fetal and childhood development.
A previous study by the same group, released in 2005, had shown that blood C8 levels in Little Hocking public water users were approximately 80 times those observed in the general U.S. population. The current study was performed because studies from other institutions had suggested that mothers with significantly lower C8 levels as compared to those found in the Little Hocking residents may be at risk for delivering newborns with lowered birth weights.
C8 is the commonly used name for perfluorooctanoic acid, or PFOA – a chemical used in the production of fluoropolymers. This chemical is used to manufacture non-stick surfaces for cookware as well as to make clothing, carpeting, and other products resistant to grease, water, and stains. According to manufacturers, C8 is not present in the final products. However, C8 is very persistent in the environment and is not biodegraded. Once inside the human body, it is very slowly eliminated. Since being found in Little Hocking water, C8 has been found to contaminate other water supplies in the Ohio Valley, as well as in Minnesota, New Jersey, and other states, in addition to other countries such as Germany.
C8 has now been removed from the public water supply in Little Hocking through a new water treatment facility. Most residents took advantage of an offer of free bottled water following the release of previous studies; however, prior to the implementation of these interventions in September 2005, Little Hocking Water District residents were found to have the highest blood C8 levels ever recorded in a general population. When researchers compared the birth weights and gestational ages of newborns in the Little Hocking Water District prior to September 2005 and compared them to the birth weights and gestational ages of unexposed control newborns, no significant differences were observed.
“Birth weight and gestational age distributions for PFOA-exposed and unexposed populations were virtually identical,” said co-author Edward Emmett, MD, MS, Deputy Director, Center of Excellence in Environmental Toxicology at Penn. More importantly, the risk of low birth weight (defined as a birth weight of less than 2500 grams/5 pounds, 8 ounces) and the risk of premature birth (defined as less than 37 weeks of gestation) between populations were not statistically different. Both low birth weight and premature birth are risk factors for the development of chronic diseases later in life including coronary heart disease, hypertension and type-2 diabetes.
Although C8 was not associated with lowered birth weight or increased risk of preterm birth, Emmett noted that additional research is still required to confirm these findings and to investigate the other potentially adverse health effects of C8 on fetal and childhood development.
Additional study authors include lead authors Lynda Nolan MSN, MPH, CRNP, a specialist perinatal nurse practitioner at Penn and epidemiologist John Nolan, MPH;
Frances Shofer, Ph.D, an epidemiologist in the Department of Emergency Medicine, Hospital of the University of Pennsylvania; and Nancy Rodway, MD, MPH, a specialist in Occupational and Environmental Medicine, who previously practiced in Chillicothe, Ohio and is now an Assistant Professor at the Ohio State University.
This study – which was independent of any corporation, law firm, or class-action suit – arose out of research that had been funded through an Environmental Justice Partnership grant from the National Institute of Environmental Health Sciences, which was specifically designed as a collaborative initiative among environmental health scientists at the University of Pennsylvania’s School of Medicine, the Decatur Community Association in Cutler, Ohio, and local community physicians.
PENN Medicine is a $3.6 billion enterprise dedicated to the related missions of medical education, biomedical research, and excellence in patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.
Penn's School of Medicine is currently ranked #4 in the nation in U.S.News & World Report's survey of top research-oriented medical schools; and, according to most recent data from the National Institutes of Health, received over $379 million in NIH research funds in the 2006 fiscal year. Supporting 1,700 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.
The University of Pennsylvania Health System (UPHS) includes its flagship hospital, the Hospital of the University of Pennsylvania, rated one of the nation’s top ten “Honor Roll” hospitals by U.S.News & World Report; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center. In addition UPHS includes a primary-care provider network; a faculty practice plan; home care, hospice, and nursing home; three multispecialty satellite facilities; as well as the Penn Medicine Rittenhouse campus, which offers comprehensive inpatient rehabilitation facilities and outpatient services in multiple specialties.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.